Global $3 Bn Large Molecule Bioanalytical Testing Services Markets, 2016-2020 & 2021-2028 – ResearchAndMarkets.com

Global $3 Bn Large Molecule Bioanalytical Testing Services Markets, 2016-2020 & 2021-2028 – ResearchAndMarkets.com




Global $3 Bn Large Molecule Bioanalytical Testing Services Markets, 2016-2020 & 2021-2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis Report by Phase (Preclinical, Clinical), by Test Type (PK, PD), by Type, by Therapeutic Area, by End User, and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering.

The global large molecule bioanalytical testing services market size is expected to reach USD 3.0 billion by 2028, expanding at a CAGR of 9.5%.

The major factor attributing to market growth is the increased application of bioanalytical testing in clinical trials of biomarkers, large molecules, and others.

Rising prevalence of HIV, infectious disease, and others has led to increasing demand for bioanalytical testing services globally. Moreover, increasing government initiatives to control the outbreak of various infectious diseases such as Corona and Ebola virus is anticipated to offer more opportunities for the market. Hence, the market is expected to grow over the assessment period.

The market is expected to witness lucrative growth during the forecast period due to increased research activities and the presence of a huge pipeline of peptides, biologics, and amino acids based molecules. Additionally, bioanalysis of large molecules requires skilled professionals with innovative analytical instruments and infrastructure. These services are readily offered by bioanalytical testing service providers and are likely to propel the growth of the market during the assessment period.

North America accounted for the highest share in 2019. The U.S. holds the highest market share due to the increasing prevalence of various chronic diseases and the growing adoption of large molecule therapeutics as an alternative for small molecules.

For example, according to International Diabetes Federation Report 2019, around 49.0 million geriatric population in the U.S. has diabetes and this has led to increasing requests for bioanalysis of the novel (large molecule compounds) peptide therapeutics such as glucagon-like peptide 1(GLP-1). Due to this reason, the market is expected to show growth over the forecast period. In addition, the presence of major players in the region contributed to market growth.

Large Molecule Bioanalytical Testing Services Market Report Highlights

  • By type, the clinical segment held the largest market share in 2019 owing to increasing demand for clinical trials due to the rising prevalence of various infectious diseases
  • Bioavailability held the largest market share of 20.9% in 2019 owing to increasing adoption in generic drug manufacturing
  • The oncology segment held the largest revenue share due to the increasing prevalence of cancer globally
  • The U.S. is expected to witness the fastest growth over the forecast period owing to the growing adoption of advanced therapeutic techniques in the country.

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.3. Competitive Insights

Chapter 3. Large Molecule Bioanalytical Testing Services Market Variables, Trends & Scope

3.1. Market Lineage outlook

3.1.1. Parent market outlook

3.1.2. Related/ancillary market outlook

3.2. Penetration & Growth Prospect Mapping

3.3. Product Pipeline Analysis, by Service

3.4. Market Dynamics

3.4.1. Market Driver Analysis

3.4.1.1. Increasing focus on the analytical testing

3.4.1.2. Growing R&D expenditure in the pharmaceutical and biopharmaceutical industries

3.4.1.3. Rising demand for outsourcing of analytical testing

3.4.2. Market Restraint Analysis

3.4.2.1. Compliance issues while outsourcing

3.4.3. Industry Challenges

3.4.3.1. Managing the relationships

3.5. Large Molecule Bioanalytical Testing Services: Market Analysis Tools

3.5.1. Industry Analysis – Porter’s

3.5.2. PESTEL Analysis

3.5.3. Major Deals & Strategic Alliances Analysis

3.5.4. Impact of Covid -19

Chapter 4. Large Molecule Bioanalytical Testing Services Market: Segment Analysis, by Phase, 2016 – 2028 (USD Million)

4.1. Definitions & Scope

4.2. Service market share analysis, 2020 & 2028

4.3. Segment Dashboard

4.4. Global Large Molecule Bioanalytical Testing Services Market, by Phase, 2016 to 2027

4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following

4.5.1. Preclinical

4.5.1.1. With Antibody

4.5.1.2. Without Antibody (ELISA Based Assay)

4.5.2. Clinical

Chapter 5. Large Molecule Bioanalytical Testing Services Market: Segment Analysis, by Type, 2016 – 2028 (USD Million)

5.1. Definitions & Scope

5.2. Service market share analysis, 2020 & 2028

5.3. Segment Dashboard

5.4. Global Large Molecule Bioanalytical Testing Services Market, by Type, 2016 to 2028

5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following

5.5.1. Pharmacokinetics

5.5.2. ADA

5.5.3. Others

Chapter 6. Large Molecule Bioanalytical Testing Services Market: Segment Analysis, by Test Type, 2016 – 2028 (USD Million)

6.1. Definitions & Scope

6.2. Service market share analysis, 2020 & 2028

6.3. Segment Dashboard

6.4. Global Large Molecule Bioanalytical Testing Services Market, by Test Type, 2016 to 2028

6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following

6.5.1. ADME

6.5.2. PK

6.5.3. PD

6.5.4. Bioavailability

6.5.5. Bioequivalence

6.5.6. Other Tests

Chapter 7. Large Molecule Bioanalytical Testing Services Market: Segment Analysis, by Therapeutic Area, 2016 – 2028 (USD Million)

7.1. Definitions & Scope

7.2. Service market share analysis, 2020 & 2028

7.3. Segment Dashboard

7.4. Global Large Molecule Bioanalytical Testing Services Market, by Therapeutic Area, 2016 to 2027

7.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following

7.5.1. Oncology

7.5.2. Infectious Diseases

7.5.3. Cardiology

7.5.4. Neurology

7.5.5. Others

Chapter 8. Large Molecule Bioanalytical Testing Services Market: Segment Analysis, by End User, 2016 – 2028 (USD Million)

8.1. Definitions & Scope

8.2. Service market share analysis, 2020 & 2028

8.3. Segment Dashboard

8.4. Global Large Molecule Bioanalytical Testing Services Market, by End User, 2016 to 2028

8.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following

8.5.1. SMEs

8.5.1.1. CROs & CMOs

8.5.1.2. Sponsor Organizations

8.5.1.3. Others (Academic Institute, etc.)

8.5.2. Large Firms

Chapter 9. Large Molecule Bioanalytical Testing Services: Regional Market Analysis, 2016 – 2028 (USD Million)

9.1. Definitions & Scope

9.2. Regional Market Share Analysis, 2020 & 2028

9.3. Regional Market Dashboard

9.4. Regional Market Snapshot

9.5. Regional Market Share, 2020

9.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2028

Chapter 10. Large Molecule Bioanalytical Testing Services – Competitive Analysis

  • Covance, Inc.
  • IQVIA
  • Syneos Health
  • Charles River Laboratory International
  • ICON Plc
  • SGS SA
  • Toxikon
  • Intertek Group plc
  • Pace Analytical Services LLC
  • PPD, INC.

For more information about this report visit https://www.researchandmarkets.com/r/q48h78

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900